Back
Day Range
$17.94
$18.98
52-Week Range
$4.70
$19.62
Volume
28,226
50D / 200D Avg
$12.71
/
$9.85
Prev Close
$18.40
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -7.5 | 0.4 |
| P/B | 4.1 | 2.9 |
| ROE % | -64.1 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -131.56M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-64.06%
ROIC-37.53%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio6.29
Interest Coverage-30.34
Valuation
P/E Ratio
-7.45
P/B Ratio4.12
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -183.79M |
| ROE | -64.06% | ROA | -41.76% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -131.56M |
| ROIC | -37.53% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 6.29 |
| Interest Coverage | -30.34 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.45 | P/B Ratio | 4.12 |
| P/S Ratio | N/A | PEG Ratio | -0.19 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.37B | Enterprise Value | 1.11B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -183.79M | -108.68M | -95.73M | -56.80M | -93.04M |
| EPS (Diluted) | -2.06 | -0.15 | -2.44 | -1.84 | -3.40 |
| Gross Profit | 0.0 | -527,000.0 | -3.16M | -3.22M | 0.0 |
| Operating Income | -166.31M | -103.92M | -93.87M | -66.33M | -93.85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 440.10M | 302.15M | 124.54M | 169.99M | 164.00M |
| Total Liabilities | 107.77M | 60.70M | 46.41M | 19.08M | 12.34M |
| Shareholders' Equity | 332.33M | 241.45M | 78.13M | 150.92M | 151.66M |
| Total Debt | 0.0 | 21.85M | 14.13M | 72,000.0 | 0.0 |
| Cash & Equivalents | 257.84M | 273.74M | 99.70M | 142.14M | 133.54M |
| Current Assets | 419.32M | 281.62M | 103.87M | 146.06M | 137.22M |
| Current Liabilities | 66.70M | 38.85M | 32.25M | 17.89M | 10.41M |